Uppsala University Secures 48 Million SEK funding

Uppsala University Secures 48 Million SEK for Antibiotic Resistance Research

Facebook
Twitter
LinkedIn

Uppsala University has been granted an incredible 48 million SEK as part of Sweden’s national program. This substantial amount will support 14 innovative research projects to tackle the world’s issue of antibiotic resistance. These projects will explore essential themes of resistance mechanisms, development of diagnostics tools and address emerging public health challenges posed by AMR.

This funding strengthens Uppsala University as one of the leading universities in health and life sciences research. Uppsala remains the protector of public health and an advocate of one of the most significant problems of modern healthcare.

It complements Sweden’s broader objectives of promoting groundbreaking research and strengthening global cooperation against the looming AMR threat for the benefit of all.

Jakob Ulvsson founded it with the intention of creating a university that would successfully merge theoretical study with practical application. For centuries, this has been done, and today, Uppsala stands as a world-class academic and research university.

Sweden’s progress in implementing strategies and policies against AMR

AMR is one of the leading concerns in Sweden and has the government putting in many measures to mitigate the problem. AMR is a major threat to human and animal health as well as economic growth in Sweden, and the country has put measures in place to combat the threat. As simple infections turn resistant to treatment, the government of Sweden recently embarked on a national AMR strategy. 

These are activities that require the involvement of other sectors and disciplines. It is implemented by the Public Health Agency of Sweden together with the Swedish Board of Agriculture, with current activities including the STRAMA program for education and follow-up. 

Sweden also involves itself with international organizations such as the United Nations and the European Union. The goal of this strategy is to make sure that by 2025, people will still have proper access to antibiotics. Furthermore, it also safeguards contemporary medical facilities and the earth’s sustainable farming systems.

Investees

Uppsala University
ESTD: 1477
Health Tech Service